Riviciclib is a potent inhibitor of cyclin-dependent kinase (CDK)(CDK9-cyclinT1, CDK4-cyclin D1, and CDK1-cyclinB with IC50s of 20 nM, 63 nM, and 79 nM, respectively),with antitumor activity on cisplatin-resistant cells.
Molecular Weight:
401.84
CAS Number:
[920113-02-6]
Formula:
C21H20ClNO5
Target:
CDK|||Others
T12737
* VAT and and shipping costs not included. Errors and price changes excepted